Venetoclax Plus Zanubrutinib for the Treatment of Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

NCT07734038 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
155
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Kerry Rogers

Collaborators